Lab21 has entered into a collaboration agreement with IntegraGen for the development of a microRNA assay for colorectal cancer. Under the partnership, Lab21 will utilize its proprietary SPARQ PCR technology to develop a CE marked assay ...
Tags: colorectal cancer assay, IntegraGen, microRNA biomarker
Reedy Acquisitions has agreed to buy South Carolina-based laboratory operations of Lab21,which provides diagnostic products and services. Supporting blood bank screening,medical diagnostics and drug discovery services,Lab21's products ...
Tags: Reedy Acquisitions, financial details, blood bank screening
Lab21 has entered into a collaboration agreement to develop polymerase chain reaction-based assays on BD Diagnostics' automated BD MAX molecular system for a series of oncology markers. The two assays, which will be initially developed, ...
Tags: Lab21, collaboration agreement, BD Diagnostics, reaction-based assays